Clobazam

Form: Oral suspension

Strength: 2.5 mg/mL (US)

Reference Brands: Onfi®

Category: Antipsychotropic Drugs

Clobazam is a 1,5-benzodiazepine used primarily as an adjunctive treatment for seizures in Lennox-Gastaut syndrome and for anxiety disorders. It is available as oral tablets (5 mg, 10 mg, 20 mg) and oral suspension (2.5 mg/mL). Marketed under brands such as Onfi®, Sympazan®, and Frisium®, Clobazam offers effective GABAergic modulation with a favorable side-effect profile. Pharma B2B platforms offer Clobazam bulk procurement from GMP and US FDA/EU-approved facilities, ensuring quality assurance, consistent supply, and compliance. Suitable for neurology clinics, hospital pharmacies, and international distributors requiring reliable access to anticonvulsant and anxiolytic therapies.